Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × surufatinib × Clear all

NCT04653480 2023-07-17

Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms